An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer

Posted by & filed under Uncategorized.

“Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access to health care has changed.” The study linked below was co-authored by two of our very own – Dr. Gregory Vidal and Andrea Curry, and compares self-reported… Read more »

Cancer Watch: Clinical Trial with 100% Response Rate

Posted by & filed under Uncategorized.

We have advanced by leaps and bounds in our collective fight against cancer over the last several years. Because of #ClinicalResearch, patients around the world can benefit from new treatments offering improved efficiency, less negative sides effects, and increased survivorship rates. We are so excited to share that an amazing new trial for malignant skin… Read more »

Breast Cancer Disparities with Dr. Greg Vidal

Posted by & filed under Uncategorized.

The West Cancer Foundation recently sat down with Dr. Greg Vidal to talk about #breastcancer disparities. A 2014 study funded by the AVON Foundation discovered that Memphis had the highest national rate of breast cancer disparities among black women. They were dying of breast cancer at two times the rate of white women. Since this… Read more »

Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute’s Ari Vanderwalde, MD, MPH is a SWOG (a National Cancer Institute supported organization that conducts clinical trials in adults) investigator and study chair for a trial that addresses advanced melanoma patients who are resistant to PD-1 inhibitors. Over 40% of these patients don’t respond to PD-1 inhibitors, widely used… Read more »

New Breast Conservation Surgery Clinical Trial

Posted by & filed under Uncategorized.

Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee Pivotal study to determine the impact of Perimeter B-Series OCT with ImgAssist AI on positive margin rates during breast conservation surgery    Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery… Read more »

Dr. Noam VanderWalde Publishes Study on Disparities in Older Adults

Posted by & filed under Uncategorized.

Dr. Noam VanderWalde, one of our incredible Radiation Oncologists here at West, is extremely passionate about geriatric oncology care. Below is a link to his most recent cooperative group publication, entitled “Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736).” Click the link below to read… Read more »

2021 West Oncology Conference

Posted by & filed under Uncategorized.

The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »

Dr. Grothey on the Role of Precision Medicine in CRC

Posted by & filed under Uncategorized.

Axel Grothey, MD, medical oncologist and our Director of Gastrointestinal Cancer Research, discusses the role of precision medicine in colorectal cancer (CRC) with OncLive. Grothey says, “With the rise of molecular profiling, the field of CRC has shifted away from a one-size-fits-all approach and entered an era of precision medicine. Notably, molecular profiling guides the… Read more »

West’s Director of Research Participated in the Clinical Trials for a COVID-19 Vaccine

Posted by & filed under Uncategorized.

Ari VanderWalde, MD, MPH, Bioeth, West Cancer Center and Research Institute’s Director of Research, stands behind the safety and highly regulated protocols for participants in clinical trials. Dr. VanderWalde recognized the importance and urgency to create a safe and effective vaccine to combat COVID-19. “I had a 50% chance of getting the vaccine and 50%… Read more »